SI9200286B - Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent - Google Patents
Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent Download PDFInfo
- Publication number
- SI9200286B SI9200286B SI9200286A SI9200286A SI9200286B SI 9200286 B SI9200286 B SI 9200286B SI 9200286 A SI9200286 A SI 9200286A SI 9200286 A SI9200286 A SI 9200286A SI 9200286 B SI9200286 B SI 9200286B
- Authority
- SI
- Slovenia
- Prior art keywords
- carboxy
- ethylamino
- formula
- propylamino
- mixture
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract 22
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical class CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 title claims abstract 6
- 239000003814 drug Substances 0.000 title claims abstract 5
- 229940124597 therapeutic agent Drugs 0.000 title claims abstract 5
- 229960003569 hematoporphyrin Drugs 0.000 title claims abstract 4
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 carboxymethylamino Chemical group 0.000 claims abstract 22
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract 7
- 150000001413 amino acids Chemical class 0.000 claims abstract 6
- 238000000034 method Methods 0.000 claims abstract 6
- 206010028980 Neoplasm Diseases 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- 239000003960 organic solvent Substances 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Chemical group NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical group OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical group NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- 239000004472 Lysine Chemical group 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Chemical group NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Chemical group NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims 2
- 229940015493 dihematoporphyrin ether Drugs 0.000 claims 2
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical group NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Chemical group OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Chemical group NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000012456 homogeneous solution Substances 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 239000011833 salt mixture Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 238000009739 binding Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL91292220A PL165249B1 (pl) | 1991-10-29 | 1991-10-29 | Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI9200286A SI9200286A (en) | 1993-06-30 |
| SI9200286B true SI9200286B (en) | 2001-06-30 |
Family
ID=20055985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9200286A SI9200286B (en) | 1991-10-29 | 1992-10-29 | Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5451599A (fi) |
| EP (1) | EP0539960B1 (fi) |
| JP (1) | JP3020759B2 (fi) |
| CN (1) | CN1040328C (fi) |
| BG (1) | BG61648B1 (fi) |
| CA (1) | CA2081605C (fi) |
| CZ (1) | CZ281694B6 (fi) |
| DE (1) | DE69217819T2 (fi) |
| DK (1) | DK0539960T3 (fi) |
| FI (1) | FI100243B (fi) |
| HR (1) | HRP921337B1 (fi) |
| LV (1) | LV11952B (fi) |
| NO (1) | NO300499B1 (fi) |
| PL (1) | PL165249B1 (fi) |
| RU (1) | RU2122003C1 (fi) |
| SI (1) | SI9200286B (fi) |
| UA (1) | UA40568C2 (fi) |
| YU (1) | YU48961B (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO180167C (no) * | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| US5948771A (en) * | 1996-01-31 | 1999-09-07 | The Trustees Of Columbia University In The City Of New York | Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
| GB9606293D0 (en) * | 1996-03-26 | 1996-05-29 | William Harvey Research Limite | Treatment of cancers and other tumours |
| AU2002222104B2 (en) | 2000-11-29 | 2007-06-28 | Pci Biotech As | Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| CZ301427B6 (cs) | 2000-11-29 | 2010-02-24 | Pci Biotech As | Zpusob zavedení molekuly do cytosolu bunky |
| CN104130266A (zh) * | 2013-05-02 | 2014-11-05 | 中国医学科学院生物医学工程研究所 | 一种新型原卟啉衍生物及制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2912M (fr) * | 1963-07-24 | 1964-11-09 | Rech S Pharma E R P H A R Soc | Dichlorhydrate d'hématoporphyrinate de procaine. |
| AU603999B2 (en) * | 1985-10-23 | 1990-12-06 | Photochemical Co., Ltd. | Porphyrin derivatives, and their production and use |
| US4882234A (en) * | 1986-11-12 | 1989-11-21 | Healux, Inc. | Storage-stable porphin compositions and a method for their manufacture |
| US5190966A (en) * | 1988-07-06 | 1993-03-02 | Health Research, Inc. | Purified hematoporphyrin dimers and trimers useful in photodynamic therapy |
| US4968715A (en) * | 1988-07-06 | 1990-11-06 | Health Research, Inc. | Use of purified hematoporphyrin trimers in photodynamic therapy |
| US4961920A (en) * | 1988-12-08 | 1990-10-09 | Luminis Pty, Ltd. | Phototherapeutic monovinyl and divinyl ether-linked dimers |
| CN102565846B (zh) * | 2011-12-30 | 2014-05-14 | 清华大学 | 蜂窝型热中子探测器 |
-
1991
- 1991-10-29 PL PL91292220A patent/PL165249B1/pl not_active IP Right Cessation
-
1992
- 1992-10-26 FI FI924856A patent/FI100243B/fi not_active IP Right Cessation
- 1992-10-28 DE DE69217819T patent/DE69217819T2/de not_active Expired - Lifetime
- 1992-10-28 DK DK92118447.9T patent/DK0539960T3/da active
- 1992-10-28 BG BG97030A patent/BG61648B1/bg unknown
- 1992-10-28 CA CA002081605A patent/CA2081605C/en not_active Expired - Lifetime
- 1992-10-28 RU RU92004314/04A patent/RU2122003C1/ru not_active IP Right Cessation
- 1992-10-28 EP EP92118447A patent/EP0539960B1/en not_active Expired - Lifetime
- 1992-10-28 NO NO924151A patent/NO300499B1/no not_active IP Right Cessation
- 1992-10-29 YU YU94592A patent/YU48961B/sh unknown
- 1992-10-29 CN CN92112561A patent/CN1040328C/zh not_active Expired - Fee Related
- 1992-10-29 SI SI9200286A patent/SI9200286B/sl not_active IP Right Cessation
- 1992-10-29 US US07/968,434 patent/US5451599A/en not_active Expired - Lifetime
- 1992-10-29 CZ CS923252A patent/CZ281694B6/cs not_active IP Right Cessation
- 1992-10-29 JP JP4291322A patent/JP3020759B2/ja not_active Expired - Lifetime
- 1992-11-24 HR HRP-945A patent/HRP921337B1/xx not_active IP Right Cessation
-
1993
- 1993-06-15 UA UA93002921A patent/UA40568C2/uk unknown
-
1997
- 1997-06-05 LV LVP-97-110A patent/LV11952B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL292220A1 (en) | 1993-09-20 |
| PL165249B1 (pl) | 1994-11-30 |
| BG97030A (bg) | 1994-03-24 |
| CN1040328C (zh) | 1998-10-21 |
| NO924151L (no) | 1993-04-30 |
| NO924151D0 (no) | 1992-10-28 |
| CA2081605A1 (en) | 1993-04-30 |
| CA2081605C (en) | 2002-02-26 |
| FI100243B (fi) | 1997-10-31 |
| US5451599A (en) | 1995-09-19 |
| HRP921337A2 (en) | 1994-10-31 |
| DE69217819T2 (de) | 1997-09-04 |
| EP0539960B1 (en) | 1997-03-05 |
| DK0539960T3 (da) | 1997-09-15 |
| CN1071914A (zh) | 1993-05-12 |
| FI924856A (fi) | 1993-04-30 |
| EP0539960A2 (en) | 1993-05-05 |
| EP0539960A3 (en) | 1993-06-16 |
| SI9200286A (en) | 1993-06-30 |
| LV11952B (en) | 1998-06-20 |
| CZ325292A3 (en) | 1993-09-15 |
| LV11952A (lv) | 1998-01-20 |
| YU48961B (sh) | 2003-01-31 |
| FI924856A0 (fi) | 1992-10-26 |
| RU2122003C1 (ru) | 1998-11-20 |
| JPH05262775A (ja) | 1993-10-12 |
| NO300499B1 (no) | 1997-06-09 |
| CZ281694B6 (cs) | 1996-12-11 |
| JP3020759B2 (ja) | 2000-03-15 |
| YU94592A (sh) | 1995-12-04 |
| DE69217819D1 (de) | 1997-04-10 |
| UA40568C2 (uk) | 2001-08-15 |
| BG61648B1 (bg) | 1998-02-27 |
| HRP921337B1 (en) | 2000-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1130316A (en) | Tri-iodated isophthalic acid diamides as non-ionic x-ray contrast agents | |
| US4410688A (en) | Macromolecular highly branched homogeneous compound | |
| EP0328529B1 (en) | Method for preparing polysubstituted diethylenetriaminepentaacetic acids | |
| DE59409995D1 (de) | Substituierte isoxazoline, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung als safener | |
| DE69032414D1 (de) | Diphenylmethane derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
| CN115768755A (zh) | 用于在流动条件下合成吸收紫外线辐射的化合物的方法及包含该化合物的制剂 | |
| US5631244A (en) | mono(6-amino-6-deoxy)cyclodextrin derivatives substituted in the 6-position by an α-amino acid residue, process for their preparation and their uses | |
| KR840000515A (ko) | N-아릴-피페라진알칸아미드의 제조법 | |
| SI9200286B (en) | Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent | |
| EP0240370B1 (en) | N-acyl substituted cyclic ureas | |
| US6291634B1 (en) | Polyamino acid derivatives | |
| JP2024505911A (ja) | アミド形成によるサルカプロジン酸の新規合成 | |
| WO2004096754A1 (ja) | 双頭型塩基性アミノ酸誘導体 | |
| KR19980702385A (ko) | 부식억제제로서 이미다졸리디논 유도체 | |
| JP2004323505A (ja) | 塩基性アミノ酸誘導体 | |
| FI111247B (fi) | Uusi b-fenyyli-isoseriinijohdannainen, sen valmistus ja käyttö | |
| Ayfer et al. | Synthesis and antibacterial activities of new quaternary ammonium monomers | |
| JP2002194080A (ja) | 重合体及びその製造方法 | |
| FR2616785A1 (fr) | Composes guanidiniques comprenant un ion tetraphenylborate substitue et procede d'obtention de ces composes et utilisation des composes lors de la synthese peptidique | |
| HU210143B (en) | Process for producing amidofluoranited compounds | |
| JPS5947033B2 (ja) | ヒドロキシ多塩基酸塩型防錆剤 | |
| EP0245631A2 (en) | Chemical process for the preparation of oxamide derivatives. | |
| US6180116B1 (en) | Histidine derivatives, preparation process and uses | |
| Knaus et al. | Photoinitiators with functional groups. Part IV. Water-soluble photoinitiators containing quaternary ammonium groups | |
| US4924006A (en) | N-pyrrolidonyl alkyl amino 1,3,4-butanetriol compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date | ||
| KO00 | Lapse of patent |
Effective date: 20120531 |